Genentech Inc - Company Profile
Powered by 
All the sales intelligence you need on Genentech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Genentech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Genentech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Genentech Inc (Genentech), a subsidiary of Roche Holding AG, discovers, develops, manufactures, and markets biotherapeutics to treat serious or life-threatening medical conditions. Product portfolio, synergy with a parent, and focus on R&D activities provide the company with a strong hold even in this competitive scenario, while the limited international footprint could be a cause for concern. Positive outlook of the global pharmaceutical market, regulatory approvals, and growing market for allergic rhinitis treatments are the opportunities for the company. However, regulations, competition, and stringent pricing pressures in the US could impact the company’s operations and its profitability.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer